Arix Bioscience (ARIX) RNS Announcements

Add to Alert list
Date Time Source Announcement
17 Apr 2023 07:00 AM
EQS
Unaudited NAV for March 2023
14 Apr 2023 12:00 PM
EQS
Notice of Results and Investor Presentation
28 Mar 2023 07:00 AM
EQS
Portfolio company Harpoon Therapeutics announce...
16 Mar 2023 07:00 AM
EQS
Unaudited NAV for February 2023
14 Feb 2023 06:18 PM
EQS
Portfolio company Disc Medicine announces $62.5...
06 Feb 2023 05:00 PM
EQS
Director/PDMR Shareholding
06 Feb 2023 07:00 AM
EQS
Unaudited NAV for January 2023
30 Jan 2023 07:00 AM
EQS
Unaudited NAV for December 2022
26 Jan 2023 07:00 AM
EQS
Board Change
05 Jan 2023 04:20 PM
EQS
Portfolio company Twelve Bio to be acquired alo...
30 Dec 2022 07:01 AM
EQS
Portfolio Company Disc Medicine Completes Merge...
12 Dec 2022 07:00 AM
EQS
Unaudited NAV for November 2022
06 Dec 2022 07:00 AM
EQS
Arix to Present at Mello Investment Trusts &amp...
01 Dec 2022 07:45 AM
RNS
Director/PDMR Shareholding
09 Nov 2022 07:00 AM
EQS
Unaudited NAV for October 2022
28 Oct 2022 07:00 AM
EQS
Director/PDMR Shareholding
20 Oct 2022 04:30 PM
EQS
Holding(s) in Company
14 Oct 2022 07:00 AM
EQS
Portfolio Company Imara Announces Merger Agreem...
11 Oct 2022 07:00 AM
EQS
Unaudited NAV for September 2022
05 Oct 2022 07:00 AM
EQS
Director/PDMR Shareholding
03 Oct 2022 04:31 PM
EQS
Arix Portfolio Company Aura Biosciences Present...
15 Sep 2022 07:00 AM
EQS
Unaudited NAV for August 2022
12 Aug 2022 07:00 AM
EQS
Unaudited NAV for July 2022
10 Aug 2022 06:05 PM
EQS
Artios initiates Phase 2 study of Polθ Inhibit...
10 Aug 2022 05:46 PM
EQS
Portfolio Company Disc Medicine Enters Definiti...
10 Aug 2022 07:01 AM
EQS
Arix Bioscience plc Announces Changes to Board ...
10 Aug 2022 07:00 AM
EQS
Interim Results for the Six Months Ended 30 Jun...
03 Aug 2022 07:00 AM
EQS
Notice of Results & Investor Presentation
22 Jul 2022 07:00 AM
EQS
Unaudited NAV for June 2022
22 Jun 2022 04:45 PM
EQS
Holding(s) in Company
22 Jun 2022 07:00 AM
EQS
Notice of Investor Presentation
09 Jun 2022 07:00 AM
EQS
Unaudited NAV for May 2022
07 Jun 2022 04:44 PM
EQS
Result of Annual General Meeting 2022
12 May 2022 09:00 AM
RNS
Communications with Shareholders
12 May 2022 07:00 AM
RNS
Publication of Annual Report & Notice of AGM
11 May 2022 07:00 AM
EQS
Unaudited NAV for April
09 May 2022 03:28 PM
EQS
Clinical Development Update from Portfolio Comp...
05 May 2022 07:00 AM
EQS
Financial Results for the Year Ended 31 Decembe...
04 May 2022 07:00 AM
EQS
TR-1: Notification of major holdings
29 Apr 2022 10:44 AM
EQS
Unaudited NAV and Notice of Financial Results
05 Apr 2022 04:28 PM
EQS
Imara Announces Results of Interim Analyses of ...
14 Mar 2022 11:32 AM
EQS
Corporate update from portfolio company Harpoon...
25 Feb 2022 05:30 PM
RNS
Closed Period Notification
24 Feb 2022 08:00 AM
RNS
Company Secretary Change
08 Feb 2022 07:20 AM
EQS
Total Voting Rights
02 Feb 2022 01:05 PM
EQS
Clinical development update from portfolio comp...
11 Jan 2022 05:04 PM
EQS
Notification of Major Share Holding
22 Dec 2021 11:05 AM
EQS
Arix Bioscience co-leads $31 million Series A f...
17 Dec 2021 11:12 AM
EQS
Director/PDMR Shareholdings
17 Dec 2021 07:00 AM
RNS
Director/PDMR Shareholding
UK 100

Latest directors dealings